TickerFacts.

Allarity Therapeutics, Inc. (ALLR): Share Repurchases

Annual figures by period end, from SEC filings.

$3.19M
Year ended 2025-12-31
$887.0K
Trailing 12 months to 2026-06-30
2024-12-31: $02025-12-31: $3.19M$3.19M
2024-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$3.19Mn/a2026-03-30, From 2025-01-01
2024-12-31$0n/a2026-03-30, From 2024-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Allarity Therapeutics, Inc. (ALLR)2025-12-31$3.19Mn/a
ProPhase Labs, Inc. (PRPH)2024-12-31$0-100.0%
Roivant Sciences Ltd. (ROIV)2025-03-31$1.29Bn/a
Tonix Pharmaceuticals Holding Corp. (TNXP)2025-12-31$13.76Mn/a
Aspire Biopharma Holdings, Inc. (ASBP)2024-12-31$13.78M-95.2%
Alumis Inc. (ALMS)2025-12-31$17.0K+183.3%
Earth Science Tech, Inc. (ETST)2026-03-31$471.4K-67.8%
Sunshine Biopharma Inc. (SBFM)2025-12-31$0-100.0%
Lftd Partners Inc. (LIFD)2025-12-31$0-100.0%

Compare ALLR, PRPH, ROIV, TNXP side by side · Screen every company in Pharmaceutical Preparations ↗